Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2000
09/21/2000CA2364046A1 Food complement and method for cosmetic treatment based on a grape extract rich in polyphenols
09/21/2000CA2363705A1 Devices and methods for pain management
09/21/2000CA2363496A1 Differential expression of organellar gene products
09/21/2000CA2363022A1 49 human secreted proteins
09/21/2000CA2362532A1 Screening of antiviral compounds targeted to the hiv-1 gp41 core structure
09/21/2000CA2361939A1 Modified amino acid amides, pharmaceutical compositions containing these compounds and processes for preparing them
09/21/2000CA2361819A1 Amide derivatives
09/21/2000CA2361810A1 Pharmaceutical composition based on polyaromatic compounds
09/21/2000CA2361770A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
09/21/2000CA2361503A1 Corticosteroid formulation
09/21/2000CA2360888A1 Method for the identification and removal of nits from hair
09/21/2000CA2332767A1 Dhea composition and method
09/21/2000CA2332427A1 Prostaglandin ep4 receptor agonist and treatment method
09/21/2000CA2332375A1 Cervical ripening agent and cervical ripening method
09/20/2000EP1036798A1 Peptides having anti-cell adhesion activity
09/20/2000EP1036794A1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
09/20/2000EP1036783A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt
09/20/2000EP1036565A1 Preventives/remedies for diabetes
09/20/2000EP1036564A1 Thyromimetic antiobesity agents
09/20/2000EP1036562A1 Soft-pellet drug and process for the preparation thereof
09/20/2000EP1036561A1 Buccal, non-polar spray
09/20/2000EP1036510A2 Vitamin formulation for cardiovascular health
09/20/2000EP1036188A1 ribG
09/20/2000EP1036187A1 Process for the preparation of immunomodulatory polysaccharides from aloe
09/20/2000EP1036178A1 Identification of lysolipid receptors involved in inflammatory response
09/20/2000EP1036175A1 Human brain derived kcnq2 potassium channel
09/20/2000EP1036169A1 Nucleic acid mediated rna tagging and rna revision
09/20/2000EP1036167A2 Nuclear targeting by means of streptococcal protein h
09/20/2000EP1036165A1 Human rnase h and compositions and uses thereof
09/20/2000EP1036084A1 Chemical synthesis of 6-o-alkyl erythromycin c
09/20/2000EP1036083A2 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
09/20/2000EP1036078A1 Thienopyrimidines
09/20/2000EP1036076A1 Novel compounds
09/20/2000EP1036075A1 Substituted thiazolidinedione and oxazolidinedione having antidiabetic, hypolipidemia and antihypertensive properties
09/20/2000EP1036074A1 S-oxide and s,s-dioxide tetrahydrothiopyran phenyloxazolidinones
09/20/2000EP1036073A1 (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
09/20/2000EP1036072A1 Thrombin receptor antagonists
09/20/2000EP1036069A1 Benzenesulfonamide compounds
09/20/2000EP1036067A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
09/20/2000EP1036065A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
09/20/2000EP1036064A1 Selective beta 3-adrenergic agonists
09/20/2000EP1036063A1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
09/20/2000EP1036062A1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
09/20/2000EP1036060A2 Cyclohexadiene-derivatives as pesticides
09/20/2000EP1036059A1 Adamantane derivatives
09/20/2000EP1036058A1 Adamantane derivatives
09/20/2000EP1036057A1 Radio-opaque polymer biomaterials
09/20/2000EP1035870A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
09/20/2000EP1035869A1 Chemically and thermally stable norastemizole formulations
09/20/2000EP1035868A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
09/20/2000EP1035859A1 THE USE OF PHOSPHOLIPID COMPLEXES OF EXTRACTS OF $i(VITIS VINIFERA) AS ANTI-ATHEROSCLEROTIC AGENTS
09/20/2000EP1035858A1 Use of ginkgo biloba extracts for preparing a medicine
09/20/2000EP1035857A1 Oral antioxidant preparation comprising selenium and reduced glutathione
09/20/2000EP1035854A1 Use of alpha-glucosidase inhibitors for treating high-risk impaired glucose tolerance
09/20/2000EP1035853A1 Use of f prostanoid receptor agonists for treating a bone disorder
09/20/2000EP1035851A2 Method for combating obesity
09/20/2000EP1035848A1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels
09/20/2000EP1035847A1 Stable solution of zinc and bicarbonate ions
09/20/2000EP1035846A2 Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
09/20/2000EP1035845A1 Modulators of cysteine protease
09/20/2000EP1035844A1 The use of polyols in combating yeast infection and polyol preparations for said use
09/20/2000EP1035843A2 I h?-MODULATORS
09/20/2000EP1035842A1 IMPROVED HMG CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATION
09/20/2000EP1035841A1 Method for producing solid dosing forms
09/20/2000EP1035840A1 Sustained release formulation containing three different types of polymers and tablet formed therefrom
09/20/2000EP1035836A1 Improved method for avoiding the degradation of an active principle
09/20/2000EP1035835A1 Long acting injectable formulations containing hydrogenated castor oil
09/20/2000EP1035833A1 Compositions for nasal administration
09/20/2000EP1035828A2 Topical compositions for regulating the oily/shiny appearance of skin
09/20/2000EP1035826A1 Hair and/or body hygienic product for human beings and animals
09/20/2000EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
09/20/2000EP1001686A4 Dehydration plant
09/20/2000EP0874805B1 Phenylacetamide derivatives
09/20/2000EP0734376B1 Vitamin d amine and amide derivatives
09/20/2000EP0707564B1 Difluoro statone analogs
09/20/2000EP0705816B1 Benzene derivative useful for ischemic diseases
09/20/2000EP0696288B1 Quinoxalindione derivatives, their preparation and their use in drugs
09/20/2000CN1267307A Interleukin-18 binding proteins, their preparation and use
09/20/2000CN1267303A 3-substd. 3,4,5,7-tetrahydro-pyrrolo [3',4' : 4,5] thieno [2,3-d] pyrimidine derivs, their preparation and use as 5HT antagonists
09/20/2000CN1267302A Benzo (5,6) cycloheptapyridine compounds useful as farnesyl protein transferase inhibitors
09/20/2000CN1267300A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs useful for inhibition of farnesyl protein transferase
09/20/2000CN1267299A Aminooxyamide tricyclic inhibitors of farnesylprotein transferase
09/20/2000CN1267298A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs useful for inhibition of farnesyl-protein transferase
09/20/2000CN1267297A Benzo (5,6) cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
09/20/2000CN1267296A Barbituric acid derivs with antimetastatic and antitumor activity
09/20/2000CN1267294A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs. for inhibition of farnesyl-protein transferase
09/20/2000CN1267293A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs. useful for inhibition of farnesyl-protein transferase
09/20/2000CN1267292A Phenyl-substd. tricyclic inhibitors of farnesyl-protein transferase
09/20/2000CN1267291A N-substituted urea inhibitors of farnesyl-protein transferase
09/20/2000CN1267290A Tricyclic sulfonamide inhibitors of farnesyl-protein transferase
09/20/2000CN1267289A Carboxy piperidylacetamide tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases (farnesyl protein transferase inhibitors)
09/20/2000CN1267288A Tricyclic keto amide derivs. useful as farnesyl protein transferase inhibitors
09/20/2000CN1267286A 2-{3-[4-(2-t-butyl-6-trifluoromethylpyridin-4-yl) piperazin-1-yl] propylmercapto} pyrimidin-4-ol-fumarate
09/20/2000CN1267284A Carbostyril derivs. for inhibiting skin erythema and/or skin pigmentation
09/20/2000CN1267224A Treatment of acute lung injury and fibrosis with antagonists of 'alpha' V 'beta' b
09/20/2000CN1267222A Polymeric compositions
09/20/2000CN1267221A Method of enhancing bioavailability of fexofenadine and its derivs.
09/20/2000CN1267219A Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
09/20/2000CN1267218A Use of phanquinone for treatment of alzheimer's disease
09/20/2000CN1267217A Solid pharmaceutical composition contg. benzofurane derivs.
1 ... 6243 6244 6245 6246 6247 6248 6249 6250 6251 6252 6253 6254 6255 6256 6257 6258 6259 6260 6261 6262 6263 ... 7860